PCC

Are Psychedelics Cannabis 2.0? Takeaways From The Top Psychedelics Business Conference In The US

EXCLUSIVE: Johns Hopkins Professor Says Psychedelic Medicine Could Get Messy, Calling For 'Right, Smart, Non-Restrictive, Yet Preventive' Regulations

EXCLUSIVE: Making The World A Better Place, How Psychedelics Are Helping

EXCLUSIVE: Johns Hopkins Professor Says Psychedelic Medicine Could Get Messy, Calling For 'Right, Smart, Non-Restrictive, Yet Preventive' Regulations

EXCLUSIVE: Making The World A Better Place, How Psychedelics Are Helping

EXCLUSIVE: Human Connection Is Essential Element For Healing With Psychedelics

This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention

EXCLUSIVE: Human Connection Is Essential Element For Healing With Psychedelics

This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry

Reggie Watts On Cannabis And Psychedelics: 'An Opportunity To Discover Something New About Myself'

PCC Recent News

EXCLUSIVE: Berner Talks Psychedelics And The Importance Of Proper Dosing

Berner, the rapper, co-founder and CEO of the cannabis and clothing brand Cookies, spoke at Benzinga's Psychedelics Capital Conference in Miami Beach in April 2022. During the conference, he talked about the genesis of Cookies and how it evolved into a multi-million dollar brand.

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach on April 19 for a full day of networking and education.

EXCLUSIVE: Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Injury

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway.

EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space

Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock. In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy.

EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle

Psyched Wellness Ltd (OTCQB: PSYCF) plans to begin selling a psychoactive mushroom extract this summer that’s never been scheduled as a drug in the U.S.

EXCLUSIVE: ATAI Life Sciences Deploys Decentralized Approach To Transform Mental Health Treatments

ATAI Life Sciences NV (NASDAQ: ATAI) is deploying a multipronged approach to accelerate the development of mental health treatments.

EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics

If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.

EXCLUSIVE: Irwin Naturals CEO Explains Importance Of Brand In Booming Psychedelics Space

EXCLUSIVE: Phyto Partners' Larry Schnurmacher Says 'There Are Some Unicorns Among Us' In Psychedelics Sector

Larry Schnurmacher, one of Phyto Partners’ cofounders has long experience in emerging markets. His venture capital fund has greatly supported 35 cannabis companies since 2015, and, with Pytho Psyche, he began investing in psychedelics-oriented companies. More investment in this sector seems to be on the way.

EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments

For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging markets. And the psychedelic space is just that.

EXCLUSIVE: Enveric Offers Investors Rare Exposure To Both Cannabis And Psychedelic Industries

There were more than 30 different companies in the psychedelic space present at the inaugural Benzinga Psychedelics Capital Conference on Tuesday. But, Enveric is one of the only ones that offer investors exposure to both the psychedelic and cannabis space. Enveric Biosciences Inc (NASDAQ:

EXCLUSIVE: The Role Of Healing Maps In Finding Psychedelics-Assisted Therapy

Cory Jones of Healing Maps told Benzinga’s Javier Hasse at the inaugural Benzinga Psychedelics Capital Conference on Tuesday that research underway at such institutions as Johns Hopkins University and London’s Imperial College is "changing people&rs

EXCLUSIVE: Kevin O'Leary On Why Cannabis Industry Attracts 'Zero' Institutional Dollars

While “Shark Tank” judge Kevin O’Leary views legal psychedelics as a once-in-a-lifetime investment opportunity, his take on cannabis is 180 degrees away.

EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge

The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.